Gain Therapeutics Share Price (NASDAQ: GANX)
$1.97
▲
0.09
(4.79%)
Last updated on
Check the interactive Gain Therapeutics Stock chart to analyse performance
Gain Therapeutics stock performance
as on August 30, 2025 at 1:29 am IST
- Today's Low:$1.90Today's High:$2.02
3.55%
Downside
Day's Volatility :5.71%
Upside
2.23%
- 52 Weeks Low:$0.9552 Weeks High:$3.19
51.78%
Downside
52 Weeks Volatility :70.22%
Upside
38.24%
Gain Therapeutics Stock Returns
Gain Therapeutics Inc Key Stats
Check Gain Therapeutics key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.
Stock Returns calculator for Gain Therapeutics Stock including INR - Dollar returns
The Gain Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Gain Therapeutics investment value today
Current value as on today
₹1,94,707
Returns
₹94,707
(+94.71%)
Returns from Gain Therapeutics Stock
₹89,423 (+89.42%)
Dollar Returns*
₹5,284 (+5.28%)
Indian investors sentiment towards Gain Therapeutics Stock
Global Institutional Holdings in Gain Therapeutics Inc
Name
Holdings %
Vanguard Group Inc
1.49%
JONES FINANCIAL COMPANIES LLLP
1.19%
Geode Capital Management, LLC
0.79%
Marshall Wace Asset Management Ltd
0.77%
CAMBRIDGE Invest RESEARCH ADVISORS, INC.
0.50%
Gotham Asset Management, LLC
0.43%
Analyst Recommendation on Gain Therapeutics Stock
Buy
90%Buy
9%Hold
0%Sell
Based on 11 Wall street analysts offering stock ratings for Gain Therapeutics(by analysts ranked 0 to 5 stars)
- Current
- 1M Ago
- 3M Ago
Gain Therapeutics Share Price Target
What analysts predicted
Upside of 291.59%
Target:
$7.71
Current:
$1.97
Gain Therapeutics share price target is $7.71, a slight Upside of 291.59% compared to current price of $1.97 as per analysts' prediction.
Gain Therapeutics Stock Insights
Price Movement
In the last 1 month, GANX stock has moved up by 35.6%GANX vs ALNY (3 yr)
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 116.0% return, outperforming this stock by 158.6%
Gain Therapeutics Technicals Summary
Sell
Neutral
Buy
Gain Therapeutics is currently in a favorable trading position ( BUY ) according to technical analysis indicators.
Gain Therapeutics Inc Vs Peers
| Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
|---|---|---|---|---|---|
| 35.62% | 1.54% | 90.38% | -42.27% | -82.32% |
 | 6.48% | -15.2% | -50.31% | -3.3% | -2.01% |
 | 2.49% | 24.81% | 62.78% | 79.11% | 29.69% |
 | -14.45% | -19.13% | -17.84% | 34.68% | 41.87% |
 | 13.79% | 83.28% | 75.87% | 111.28% | 242.25% |
| Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
|---|---|---|---|---|---|---|---|---|
| NA | NA | NA | -0.67 | -2.4 | -0.74 | NA | 0.12 |
| 14.6 | 14.6 | 1.2 | 39.42 | 0.15 | 0.07 | 0.0 | 287.55 |
| NA | NA | NA | 2.73 | -0.05 | -0.01 | NA | 34.32 |
| 27.86 | 27.86 | 0.58 | 18.06 | 0.23 | 0.13 | NA | 67.02 |
| NA | NA | -0.49 | 3.92 | -2.58 | -0.03 | NA | 1.91 |
| Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
|---|---|---|---|---|---|
| Buy | $67.6M | -82.32% | NA | 0.0% |
| Buy | $61.4B | -2.01% | 14.6 | 31.37% |
| NA | $36.5B | 29.69% | NA | -3.89% |
| Buy | $100.5B | 41.87% | 27.86 | 31.86% |
| Buy | $59.5B | 242.25% | NA | -12.96% |
About Gain Therapeutics Inc
Key Management of Gain Therapeutics Inc
Important FAQs about investing in GANX Stock from India :
What is Gain Therapeutics share price today?
Gain Therapeutics share price today is $1.97 as on at the close of the market. Gain Therapeutics share today touched a day high of $2.02 and a low of $1.90.
What is the 52 week high and 52 week low for Gain Therapeutics share?
Gain Therapeutics share touched a 52 week high of $3.19 and a 52 week low of $0.95. Gain Therapeutics stock price today i.e. is closed at $1.97, lower by 38.24% versus the 52 week high.
How to invest in Gain Therapeutics Stock (GANX) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Gain Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Gain Therapeutics Shares that will get you 0.7614 shares as per Gain Therapeutics share price of $1.97 per share as on August 30, 2025 at 1:29 am IST.
What is the minimum amount required to buy Gain Therapeutics Stock (GANX) from India?
Indian investors can start investing in Gain Therapeutics (GANX) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Gain Therapeutics stock (as per the Rupee-Dollar exchange rate as on August 31, 2025).
Based on Gain Therapeutics share’s latest price of $1.97 as on August 30, 2025 at 1:29 am IST, you will get 5.0761 shares of Gain Therapeutics. Learn more about
fractional shares .
What are the returns that Gain Therapeutics has given to Indian investors in the last 5 years?
Gain Therapeutics stock has given -82.32% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?
Discover More
- Webs Defined Volatility Xle
$24.99
-0.04%
- United States 12 Month Natur
$7.81
+1.83%
- F/m U S T Inl-p S (tips) Etf
$50.14
+0.06%
- Pgim Jennison Focused Growth Etf
$105.89
-1.37%
Hitek Global Inc$1.49
+1.36%
Vaneck Vectors Preferred Secs Ex Finls Etf$17.68
-0.73%
Marker Therapeutics Inc$0.93
+3.33%
- Cambria Value And Momentum Etf
$32.55
+0.25%